Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Lansing
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lansing, MI

Studies commonly pay $75 to $4,500 per completed study

175 clinical trials are currently recruiting participants within 30 miles of Lansing. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

175studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Lansing right now

Top 25 of 175 recruiting studies, sorted by proximity — each links to its official registry page

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Sepsis, Systemic Inflammatory Response Syndrome N/A Observational 2,500 participants sought
University of Michigan Health/Sparrow (name change only) — Lansing, Michigan (1.3 mi) · Sponsor: Michigan State University

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements

Parkinson Disease, Atypical Parkinsonism N/A Interventional 100 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi) · Sponsor: Michigan State University

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Phase 4 Interventional 55 participants sought
MSU Center for Bleeding and Clotting Disorders — Lansing, Michigan (1.3 mi) · Sponsor: American Thrombosis and Hemostasis Network

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: National Cancer Institute (NCI)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: NRG Oncology

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma Recurrent N/A Interventional 198 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: Barbara Ann Karmanos Cancer Institute

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Lansing, Michigan (1.3 mi) · Sponsor: Medtronic

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic, Cancer N/A Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Lansing, Michigan (1.3 mi) · Sponsor: Massive Bio, Inc.

Treating Chronic Cervicogenic Head and Neck Pain

Cervicogenic Headache, Neck Pain, Posterior Phase 1, Phase 2 Interventional 30 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi) · Sponsor: Michigan State University

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Paroxysmal Atrial Fibrillation N/A Observational 250 participants sought
Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi) · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Acute Ischemic Stroke Phase 3 Interventional 404 participants sought
Michigan State University — Lansing, Michigan (1.3 mi) · Sponsor: Mercy Health Ohio

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy Phase 3 Interventional 160 participants sought
Michigan State University- Site Number : 8400038 — East Lansing, Michigan (4.2 mi) · Sponsor: Sanofi

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: National Cancer Institute (NCI)

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

Alcohol Use Disorder, Alcohol-related Liver Disease N/A Interventional 298 participants sought
Henry Ford + Michigan State University Health Center — Lansing, Michigan (1.3 mi) · Sponsor: University of Wisconsin, Madison

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
McLaren Greater Lansing — Lansing, Michigan (1.3 mi) · Sponsor: Novo Nordisk A/S

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion N/A Observational 150 participants sought
Sparrow Cancer Center — Lansing, Michigan (1.3 mi) · Sponsor: Bayer

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi) · Sponsor: PedAL BCU, LLC

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi) · Sponsor: SWOG Cancer Research Network

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast Neoplasms, Breast Cancer Phase 2 Interventional 5,000 participants sought
Herbert-Herman Cancer Center, Sparrow Hospital — Lansing, Michigan (1.3 mi) · Sponsor: QuantumLeap Healthcare Collaborative

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

Chronic Inflammatory Demyelinating Polyneuropathy Phase 3 Interventional 256 participants sought
Clinical Study Site — East Lansing, Michigan (4.2 mi) · Sponsor: Dianthus Therapeutics
Actively enrolling

Studies you may be able to join near Lansing

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Lansing

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Michigan Cancer Research Consortium

1140 E Michigan Ave, Lansing, MI 48912
(517) 364-9402

CTSI (Clinical and Translational Sciences Institute)

909 Wilson Rd Ste B500, East Lansing, MI 48824

Professional Building | UM Health-Sparrow

★ 4.4
1200 E Michigan Ave, Lansing, MI 48912
(517) 364-1000
"Made an appointment last night for this morning. The kiosk at check in said to check with staff about my appointment. Nobody ever around in the lab u…"
— Curt Barnum, 1★

Hannah Technology Research Center

★ 4.1
4660 Hagadorn Rd, East Lansing, MI 48823
(517) 332-5606
"Visiting MSU Physician. It's a nice place, lots of parking"
— Angela Christine, 5★

MSU Center for Bioethics and Social Justice

965 Wilson Rd Rm A126, East Lansing, MI 48824
(517) 355-7550

College of Veterinary Medicine

★ 3.5
784 Wilson Rd G100, East Lansing, MI 48824
(517) 353-5420
"I can not say enough wonderful things about our experience. Every single person involved in our very emergent situation was so helpful and kind. Very…"
— Kristy Moore, 5★

Mid-West Center for Sleep Disorders Lansing

★ 4.1
3937 Patient Care Dr #102/103, Lansing, MI 48911
(517) 887-6733
"This place was so awesome, the staff made me feel so comfortable and set my heart at ease about all the equipment attached to me for the sleep study,…"
— Shaun Miller, 5★

Detroit Clinical Research Center

★ 5.0
30160 Orchard Lake Rd #110, Farmington Hills, MI 48334
(248) 737-5939

Rassel-Daigneault Holistic Health Center

★ 4.8
537 N Clippert St, Lansing, MI 48912
(517) 336-8880

Clinical trials in Lansing: what's recruiting

The Lansing area currently has 175 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lansing, the most active research areas are:

  • Cancer & Oncology8 studies
  • Liver & Kidney4 studies
  • Heart & Vascular4 studies
  • Brain & Mental Health1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Lansing, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lansing

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lansing participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Lansing safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Lansing, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Lansing?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Lansing?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lansing.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lansing typically complete one or two studies per year.

Paid clinical trials near Lansing

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of MI

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts